Kidney Cancer Trial, Recruiting (NCT06290427)

Kidney Cancer Trial, Recruiting NCT06290427 Sponsor: Azienda Ospedaliera Universitaria Integrata Verona Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06290427 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 18 and 90 years old.
People who have a kidney tumor that is contained in one area and is suitable for a type of surgery that removes only part of the kidney (called a partial nephrectomy).
People who are able to understand and sign a consent form agreeing to take part in the study.
People who are able to attend and complete the required follow-up appointments and checks.

Who may not be able to join:

People who are younger than 18 or older than 90 years of age.
People whose kidney tumor is not suitable for the partial kidney removal surgery.
People who are unable to understand or sign the consent form.
People who are unable to keep up with the required monitoring and follow-up schedule.
People who do not wish to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alessandro AA Antonelli, MD, Azienda Ospedaliera Universitaria Integrata Verona

Phone: +39 0458127701

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06290427

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

Trial contact: +39 0458127701

More information: https://clinicaltrials.gov/study/NCT06290427

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 18 and 90 years old.
People who have a kidney tumor that is contained in one area and is suitable for a type of surgery that removes only part of the kidney (called a partial nephrectomy).
People who are able to understand and sign a consent form agreeing to take part in the study.
People who are able to attend and complete the required follow-up appointments and checks.

Who may not be able to join:

People who are younger than 18 or older than 90 years of age.
People whose kidney tumor is not suitable for the partial kidney removal surgery.
People who are unable to understand or sign the consent form.
People who are unable to keep up with the required monitoring and follow-up schedule.
People who do not wish to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Azienda Ospedaliera Universitaria Integrata Verona

Registry

ClinicalTrials.gov

Start date

1 February 2024

Est. completion

12 December 2024

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Number of participants with postoperative complications; Number of participants with moderate to major postoperative complications; Number of participants with major postoperative complications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov